Cord blood CD4+CD25+-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function

被引:235
作者
Godfrey, WR
Spoden, DJ
Ge, YG
Baker, SR
Liu, BL
Levine, BL
June, CH
Blazar, BR
Porter, SB
机构
[1] Univ Minnesota, Ctr Canc, Dept Pediat, Div Hematol Oncol & Transplantat, Minneapolis, MN USA
[2] Univ Minnesota, Ctr Canc, Dept Pediat, Div Hematol Oncol & Transplantat, Minneapolis, MN USA
[3] Univ Penn, Ctr Canc, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.1182/blood-2004-06-2467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD4(+)CD25(+) T regulatory (T-reg) cells have been shown to critically regulate self and allograft tolerance in mice. Studies of human T-reg cells have been hindered by low numbers present in peripheral blood and difficult purification. We found that cord blood was a superior source for T-reg-cell isolation and cell line generation compared with adult blood. Cord blood CD4(+)CD25(+) cells were readily purified and generated cell lines that consistently exhibited potent suppressor activity, with more than 95% suppression of allogeneic mixed lymphocyte reactions (MLRs) (29 of 30 donors). Cultured T-reg cells blocked cytokine accumulation in MLRs, with a less robust inhibition of chemokine production. These cell lines uniformly expressed CD25, CD62L, CCR7, CD27, and intracellular cytotoxic T-lymphocyte antigen-4 (CTLA4). FoxP3 protein, but not mRNA, was specifically expressed. Upon restimulation with anti-CD3/CD28 beads, the cultured T-reg cells produced minimal cytokines (interleukin-2 [IL-2], interferon-gamma [IFN-gamma], and IL-10) and preferentially expressed tumor growth factor-beta (TGF-beta) latency associated protein. Cytokine production, however, was restored to normal levels by restimulation with phorbol myristate acetate (PMA)/ionomycin. Cord blood-derived cultured suppressor cell function was predominantly independent of IL-10 and TGF-beta. These results demonstrate cord blood contains a significant number of T-reg precursor cells capable of potent suppressor function after culture activation. Banked cord blood specimens may serve as a readily available source of Treg cells for immunotherapy. (C) 2005 by The American Society of Hematology.
引用
收藏
页码:750 / 758
页数:9
相关论文
共 44 条
[1]   Origin of regulatory T cells with known specificity for antigen [J].
Apostolou, I ;
Sarukhan, A ;
Klein, L ;
von Boehmer, H .
NATURE IMMUNOLOGY, 2002, 3 (08) :756-763
[2]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[3]   Human CD4+CD25+ regulatory T cells [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
SEMINARS IN IMMUNOLOGY, 2004, 16 (02) :89-97
[4]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[5]   Umbilical cord blood transplantation: current practice and future innovations [J].
Barker, JN ;
Wagner, JE .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 48 (01) :35-43
[6]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[7]   Maturation, activation, and protection of dendritic cells induced by double-stranded RNA [J].
Cella, M ;
Salio, M ;
Sakakibara, Y ;
Langen, H ;
Julkunen, I ;
Lanzavecchia, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :821-829
[8]   TGF-β:: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression [J].
Chen, WJ ;
Wahl, SM .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (02) :85-89
[9]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[10]   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation [J].
Edinger, M ;
Hoffmann, P ;
Ermann, J ;
Drago, K ;
Fathman, CG ;
Strober, S ;
Negrin, RS .
NATURE MEDICINE, 2003, 9 (09) :1144-1150